BACk Pain in Elders in Norway (BACE-N) (BACE-N)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04261309 |
Recruitment Status :
Completed
First Posted : February 7, 2020
Last Update Posted : September 30, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Back Pain | Other: Usual care |

Study Type : | Observational |
Actual Enrollment : | 452 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | BACk Pain in Elders in Norway (BACE-N); A Prospective Cohort Study of Older People Visiting Primary Care With a New Episode of Back Pain |
Actual Study Start Date : | January 15, 2017 |
Actual Primary Completion Date : | March 15, 2022 |
Actual Study Completion Date : | March 15, 2022 |
Group/Cohort | Intervention/treatment |
---|---|
Elderly with back pain in primary healthcare
Consecutive women and men 55 years of age or older who seek primary care (GP, physiotherapist or chiropractor) with a new episode of back pain (preceded by 6 months without visiting a primary care provider for similar complaints)
|
Other: Usual care
Since this is an observational study there will be no interference with the care given by the primary healthcare providers. However, the usual care provided by these and other healthcare utilization used by the patients during follow-up will be recorded during the follow-ups. |
- the Roland Morris Disability Questionnaire [ Time Frame: 12 months follow-up ]Scores range from 0 to 24. Higher scores indicate more severe pain and disability.
- the Roland Morris Disability Questionnaire [ Time Frame: 24 months follow-up ]Scores range from 0 to 24. Higher scores indicate more severe pain and disability.
- Numerical Pain Rating Scale [ Time Frame: 12 months follow-up ]pain severity for back and leg pain assessed on a score from 0 (no pain) to 10 (maximum pain). Back and leg pain is scored separately.
- Numerical Pain Rating Scale [ Time Frame: 24 months ]pain severity for back and leg pain assessed on a score from 0 (no pain) to 10 (maximum pain). Back and leg pain is scored separately.
- Overall recovery [ Time Frame: 12 months follow-up ]Global perceived effect scale (7-point ordinal scale)
- Overall recovery [ Time Frame: 24 months follow-up ]Global perceived effect scale (7-point ordinal scale)
- Costs of healthcare utilization [ Time Frame: 12 months follow-up ]Costs summarised for type and frequency of health care, including consultations, medication, treatment, diagnostic examinations, hospitalisation/institutionalisation, and operations.
- Costs of healthcare utilization [ Time Frame: 24 months follow-up ]Costs summarised for type and frequency of health care, including consultations, medication, treatment, diagnostic examinations, hospitalisation/institutionalisation, and operations.
- Number of falls during follow-up [ Time Frame: 12 months follow-up ]number of falls, including description of cause of the fall
- Number of falls during follow-up [ Time Frame: 24 months follow-up ]number of falls, including description of cause of the fall
- Insomnia [ Time Frame: 12 months follow-up ]Bergen Insomnia Scale, 6 items assessing sleep onsent, maintenance and early morning wakening insomnia.
- Insomnia [ Time Frame: 24 months follow-up ]Bergen Insomnia Scale, 6 items assessing sleep onsent, maintenance and early morning wakening insomnia.
- Symptomatic State [ Time Frame: 12 months follow-up ]the Patient Acceptable Symptomatic State (PASS) (5-point ordinal scale)
- Symptomatic State [ Time Frame: 24 months follow-up ]the Patient Acceptable Symptomatic State (PASS) (5-point ordinal scale)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- seek primary care (GP, physiotherapist or chiropractor)
- new episode of back pain
- no visit of primary care the preceding 6 months for back pain
Exclusion Criteria:
- cognitive impairments
- difficulties speaking and writing Norwegian
- severe mobility impairments (can not attend physical examination)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04261309
Norway | |
Tåsen og Ullevål fysioterapi | |
Oslo, Norway, 0876 |
Documents provided by Margreth Grotle, Oslo Metropolitan University:
Responsible Party: | Margreth Grotle, Professor, Oslo Metropolitan University |
ClinicalTrials.gov Identifier: | NCT04261309 |
Other Study ID Numbers: |
BACE |
First Posted: | February 7, 2020 Key Record Dates |
Last Update Posted: | September 30, 2022 |
Last Verified: | September 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | BACE-N is part of the international BACE consortium. We plan to share BACE-N with other BACE researchers in the Netherlands. |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR) |
Time Frame: | from June 2021 and maximum 10 years (due to data storing policy in Norway) |
Access Criteria: | Only anonymous data will be shared. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
prognosis, prognostic factors, subgroups, burden of disease, |
Back Pain Pain Neurologic Manifestations |